+30.4%
GSK vs CYCU
-92.3%
+122.7%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CYCU | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -1.4% | -0.5% | -1.9% |
| 7D | -1.8% | -8.1% | +6.2% | -1.9% |
| 30D | -2.2% | -43.0% | +40.8% | -2.3% |
| 3M | -1.8% | -50.8% | +49.0% | -0.2% |
| 6M | -10.6% | -74.1% | +63.5% | -9.3% |
| YTD | +4.4% | -84.0% | +88.4% | +5.9% |
| 1Y | +30.4% | -92.2% | +122.6% | +32.7% |
| All | +30.4% | -92.3% | +122.7% | +32.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CYCU.
Daily Out/Under-Performance
Portfolio return minus CYCU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CYCU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CYCU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling